Spotlight On: EXOMIND

Published

Written by...

Share this article

A new brain stimulation therapy used to support mental wellbeing

Mental wellness has been identified as the number one health concern among adults, surpassing cancer and obesity.1 It has also been found that 50% of aesthetic patients are struggling with their mental health.2
To help combat this, a new device, EXOMIND, has recently been introduced by BTL Aesthetics into some UK aesthetic and regenerative clinics. With more aesthetic clinics onboarding more wellness, health and longevity services, this new approach is well suited to many clinics.
Clinical background
Transcranial magnetic stimulation (TMS) has been used in psychiatric medicine for more than four decades as a non-invasive treatment for certain mental health conditions such as depression and anxiety.3
TMS received US FDA clearance in 2008 for depression and has an extensive safety record in psychiatric use.4 Using this technology, EXOMIND has been US FDA-cleared for depression and CE-marked in…

Subscriber content

Continue reading this clinical article

To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.